StarZero All shows Try the podcast clipper →

3x1 Partners

5 statements across 1 episodes · 4 bullish · 0 bearish · 1 people on the record · first statement Apr 28, 2025 by Rodrigo Bitar · said 3 times in 1 episodes since 2025 · across every show →

Mentions by year

brought up most by Ted Seides (3)

tap a year for its mentions
0021312025episodesmentions
0112025episodes it came up in
001.50.5312025episodesmentions per episode
2025 3 mentions in 1 episode

every mention, scene by scene, with the transcript →

Everything said about 3x1 Partners, oldest first

Apr 28, 2025 positive
Disclosure
Bitar: 3x1 quintupled average employee compensation across its Venezuelan portfolio
“So our employees and the companies in Venezuela, I think we've Can tuple the average compensation since we began four years ago.”
Rodrigo Bitar Apr 28, 2025 ▶ 36:11 Rodrigo Bitar – Overlooked Opportunities in Latin America (EP.442)
Apr 28, 2025 bullish
Assertion Partly supported
Bitar: 3x1 grew a Venezuelan pharma asset from #6 to #2
“So we followed that playbook and we began acquiring a company that was the number six in the market. And in the span of a little bit less than three years, it's become the number two pharmaceutical manufacturer. So that's meant about a tripling or quadrupling …”
Rodrigo Bitar Apr 28, 2025 ▶ 13:18 Rodrigo Bitar – Overlooked Opportunities in Latin America (EP.442)
Apr 28, 2025 bullish
Assertion Not checkable as stated
Bitar: 3x1 Partners' portfolio grew 40% annually over four years
“Our portfolio has grown about 40% per annum the last four years”
Rodrigo Bitar Apr 28, 2025 ▶ 10:03 Rodrigo Bitar – Overlooked Opportunities in Latin America (EP.442)
Apr 28, 2025 positive
Assertion Supported
Bitar: Latin American regional platforms command 10x to 14x EBITDA
“When you look at the latest transactions in the past five, six years in Latin America, all these regional guys have gone from like 10 to 14 times EBITDA. And the going in price for these assets is like seven to eight times EBITDA.”
Rodrigo Bitar Apr 28, 2025 ▶ 32:04 Rodrigo Bitar – Overlooked Opportunities in Latin America (EP.442)
Apr 28, 2025
Disclosure
Bitar: 3x1 acquired Pfizer's Venezuelan assets at ~3.5x to 4x EBITDA
“And then we subsequently acquired the assets of Pfizer in Venezuela. And then we subsequently last year acquired local assets Of a company called Vivas Pharmaceuticals, and the multiples were all around there.”
Rodrigo Bitar Apr 28, 2025 ▶ 21:23 Rodrigo Bitar – Overlooked Opportunities in Latin America (EP.442)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 700 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more